MARIA DE LA PALOMA
MONLLOR TALTAVULL
Investigadora en el periodo 2018-2020
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (7)
2021
-
Electroencephalography as a non-invasive biomarker of alzheimer’s disease: A forgotten candidate to substitute CSF molecules?
International Journal of Molecular Sciences, Vol. 22, Núm. 19
-
Is Oxidative Stress the Link Between Cerebral Small Vessel Disease, Sleep Disruption, and Oligodendrocyte Dysfunction in the Onset of Alzheimer’s Disease?
Frontiers in Physiology, Vol. 12
-
Serum levels of clusterin, PKR, and RAGE correlate with amyloid burden in Alzheimer's disease
Journal of Alzheimer's Disease, Vol. 80, Núm. 3, pp. 1067-1077
2020
-
Is sleep disruption a cause or consequence of alzheimer’s disease? Reviewing its possible role as a biomarker
International Journal of Molecular Sciences, Vol. 21, Núm. 3
2019
-
Obesity as a risk factor for Alzheimer's disease: Implication of leptin and glutamate
Frontiers in Neuroscience, Vol. 13, Núm. MAY
-
The effectiveness of vitamin E treatment in alzheimer’s disease
International Journal of Molecular Sciences, Vol. 20, Núm. 4
-
When does Alzheimer′s disease really start? The role of biomarkers
International Journal of Molecular Sciences, Vol. 20, Núm. 22